Latest Operating Expenses News

Southern Cross Media Group’s FY26 results reveal a 4.5% revenue drop amid a soft advertising market, but $30 million in merger synergies delivered a year early and digital revenue growth offer a silver lining.

Kip McGrath Education Centres narrowed its revenue by 4.3% to $30.1 million in FY26 while lifting profit after tax by 2.1%, driven by strategic franchise consolidation and operational efficiencies. The company also faced an unsolicited takeover bid post-reporting period.

News Corp posted a 7% revenue increase to $9.028 billion in fiscal 2026, driven by gains across its key segments, while net income attributable to stockholders fell 51% due to absence of prior discontinued operations income.

Westpac Banking Corporation reported a 3% increase in statutory net profit to $1.8 billion in Q3 2026, supported by loan and deposit growth alongside stable capital ratios and ongoing transformation efforts.

Flagship Investments Limited reported a sharp 24.1% portfolio decline for the year ended 30 June 2026, underperforming the ASX All Ordinaries Index by 21.7 percentage points. Despite this, the company declared a fully franked final dividend of 5.3 cents per share, supported by retained earnings.

Elixinol Wellness (ASX: EXL) has posted a record quarterly revenue of A$4.3 million alongside a 45% gross margin, marking a clear shift from its US CBD origins to a diversified Australian wellness platform. Cost reductions and disciplined cash flow management underpin the company’s readiness to scale.

AVITA Medical posted robust Q2 2026 results with 18% revenue growth, driven by RECELL and supported by Cohealyx and PermeaDerm, and now expects to reach cash flow breakeven by year-end.

REA Group Ltd (ASX:REA) posted a robust FY26 with revenue up 7% to A$1.793 billion and core net profit rising 15% to A$682 million, supported by record audience engagement and strategic AI investments.

AoFrio’s revenue fell 21.5% in 1H26, dragged down by a 50.5% plunge in motor sales due to US tariffs, while IoT revenue grew modestly. The company launched new cellular and software platforms, raised NZD 8.9 million, and is expanding into Food Retail, but full-year revenue growth now looks unlikely.

Vitrafy Life Sciences reported an 80% revenue surge and halved its net loss, buoyed by US military validation and major blood network partnerships. A $32 million capital raise fuels its US commercial expansion and manufacturing scale-up.

Singular Health deepens US healthcare foothold with ongoing Triple-S contract talks, PNS licence expansion, and Miami-Dade educational rollout, supported by a solid $10.1 million cash reserve.

Neurotech International has secured FDA clearance for its NTI164 Investigational New Drug application and obtained Notices of Allowance for two US patents, advancing its Phase 3 autism spectrum disorder program.